Singedas, Newnamae .
HRN: 22-74-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2025
CEFUROXIME 500MG (TAB)
07/04/2025
07/11/2025
PO
500mg
BID
S/P Exlap Salpingectomy
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines